Using Ras-activated cancer cells and clinical samples from patients with colorectal and lung adenocarcinomas, we have described the underlying mechanism for cross-activation, positive cross-talk, between the Ras/Raf/MEK/ERK and PI3K/AKT/mTOR pathways through PIK3IP1 suppression8. Here, PIK3IP1 is linked to cancer.